Toyonaka, Japan

Hiromi Sato


Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Takarazuka, JA (1976 - 1977)
  • Osaka, JA (1977)
  • Toyonaka, JP (1980 - 1987)

Company Filing History:


Years Active: 1976-1987

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hiromi Sato: Innovator in Anti-Cancer Chemical Agents

Introduction

Hiromi Sato is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of anti-cancer agents. With a total of eight patents to his name, Sato's work focuses on creating compounds that are effective yet have lower toxicity.

Latest Patents

Sato's latest patents include innovative aminonaphthacene derivatives. One of his notable inventions is a 9-Aminonaphthacene derivative, which is characterized by a specific formula where R1 and R2 can be hydrogen or hydroxyl/methoxy groups. This compound is designed to serve as an anti-cancer chemical agent with reduced toxicity and minimal local irritation, making it suitable for oral application. Another significant patent involves a (7S,9S) isomer of the aminonaphthacene derivative, which is also aimed at being an effective anti-tumor agent.

Career Highlights

Throughout his career, Hiromi Sato has worked with prominent companies such as Sumitomo Chemical Company and Sumitomo Pharmaceuticals. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of chemical research.

Collaborations

Sato has collaborated with notable colleagues, including Hisao Yamamoto and Kikuo Ishizumi, who have contributed to his research endeavors.

Conclusion

Hiromi Sato's work in developing aminonaphthacene derivatives showcases his commitment to advancing cancer treatment through innovative chemical solutions. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…